{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:53:44Z","timestamp":1792414424065,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:00:00Z","timestamp":1760227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.urolonc.2025.10.008","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:52:05Z","timestamp":1761972725000},"page":"65.e13-65.e20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnostic performance of Cxbladder Triage Plus for the identification and stratification of patients at risk for urothelial carcinoma: The multicenter, prospective, observational DRIVE study"],"prefix":"10.1016","volume":"44","author":[{"given":"Stephen J.","family":"Savage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar E.","family":"Ercole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Hemstreet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Masterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"McWilliams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Risk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian R.","family":"Schroeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Stratton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Lough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2025.10.008_bib0001","first-page":"31","article-title":"The diagnostic value of macroscopic haematuria for the diagnosis of urological cancer in general practice","volume":"53","author":"Bruyninckx","year":"2003","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0002","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/JU.0000000000001297","article-title":"Updates to Microhematuria: AUA\/SUFU guideline (2025)","volume":"204","author":"Barocas","year":"2025","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0003","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.eururo.2022.03.027","article-title":"Systematic review of the incidence of and risk factors for urothelial cancers and renal cell carcinoma among patients with haematuria","volume":"82","author":"Rai","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0004","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.eururo.2019.04.035","article-title":"Evaluation of cxbladder and adjudication of atypical cytology and equivocal cystoscopy","volume":"76","author":"Konety","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0005","first-page":"71","article-title":"Assessment of a clinical pathway for investigation of haematuria that reduces the need for cystoscopy","volume":"133","author":"Davidson","year":"2020","journal-title":"NZ Med J"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0006","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1097\/JU.0000000000002135","article-title":"The diagnostic performance of Cxbladder Resolve, alone and in combination with other cxbladder tests, in the identification and priority evaluation of patients at risk for urothelial carcinoma","volume":"206","author":"Raman","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0007","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/JU.0000000000001550","article-title":"Evaluation of the new American Urological Association guidelines risk classification for hematuria","volume":"205","author":"Woldu","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0008","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.juro.2012.05.003","article-title":"A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria","volume":"188","author":"O'Sullivan","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0009","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12894-015-0018-5","article-title":"A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma","volume":"15","author":"Kavalieris","year":"2015","journal-title":"BMC Urol"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0010","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1158\/1078-0432.CCR-07-1672","article-title":"Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder","volume":"14","author":"Holyoake","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0011","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/JU.0000000000003126","article-title":"Urinary analysis of FGFR3 and TERT gene mutations enhances performance of cxbladder tests and improves patient risk stratification","volume":"209","author":"Lotan","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0012","first-page":"55","article-title":"Inclusion of a molecular marker of bladder cancer in a clinical pathway for investigation of haematuria may reduce the need for cystoscopy","volume":"132","author":"Davidson","year":"2019","journal-title":"NZ Med J"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0013","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/JU.0000000000003991","article-title":"A multicenter prospective randomized controlled trial comparing cxbladder triage to cystoscopy in patients with microhematuria: the safe testing of risk for asymptomatic microhematuria trial","volume":"212","author":"Lotan","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0014","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/cas.14000","article-title":"Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma","volume":"110","author":"Hayashi","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0015","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1136\/bmj.308.6943.1552","article-title":"Diagnostic tests. 1: sensitivity and specificity","volume":"308","author":"Altman","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0016","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/bmj.309.6947.102","article-title":"Diagnostic tests. 2: predictive values","volume":"309","author":"Altman","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0017","unstructured":"R Core Team, R: a language and environment for statistical computing. https:\/\/www.R-project.org\/, 2024 (accessed 9 January 2025)."},{"key":"10.1016\/j.urolonc.2025.10.008_bib0018","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cncy.20080","article-title":"A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosis","volume":"118","author":"Caraway","year":"2010","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2014.06.008","article-title":"Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer","volume":"33","author":"Yafi","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/cncy.21327","article-title":"Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation","volume":"121","author":"Dimashkieh","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0021","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4103\/0974-7796.134264","article-title":"Utility of urine cytology in evaluating hematuria with sonographically suspected bladder lesion in patients older than 50 years","volume":"6","author":"Mady","year":"2014","journal-title":"Urol Ann"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0022","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.juro.2012.10.022","article-title":"Routine urine cytology has no role in hematuria investigations","volume":"189","author":"Mishriki","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0023","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/0970-9371.93211","article-title":"Cytological findings in routine voided urine samples with hematuria from a tertiary care center in south India","volume":"29","author":"Siddappa","year":"2012","journal-title":"J Cytol"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0024","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/bju.14459","article-title":"Does urinary cytology have a role in haematuria investigations?","volume":"123","author":"Tan","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1017\/S0266462310001364","article-title":"Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: systematic review and meta-analysis","volume":"27","author":"Mowatt","year":"2011","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.urolonc.2025.10.008_bib0026","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.eururo.2007.11.048","article-title":"Photodynamic diagnosis in urology: state-of-the-art","volume":"53","author":"Jocham","year":"2008","journal-title":"Eur Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:57:32Z","timestamp":1773871052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925004053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1078143925004053"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.10.008","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic performance of Cxbladder Triage Plus for the identification and stratification of patients at risk for urothelial carcinoma: The multicenter, prospective, observational DRIVE study","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}